Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 15 January 2024 264 - Subject
- Language
- ISSN
- 0223-5234